FEops HEARTguideTM vs Zio ECG Utilization Software (ZEUS) System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by FEops nv
VS
by iRhythm Technologies

AI Verdict

FEops HEARTguideTM is designed for pre-procedural planning of structural heart interventions, utilizing AI to provide predictive simulations and anatomical insights from CT scans. In contrast, the Zio ECG Utilization Software (ZEUS) System focuses on the diagnosis and management of cardiac arrhythmias through the AI-powered analysis of continuous ECG data from wearable monitors. While both are cloud-based cardiology AI tools, they address distinct clinical problems and leverage different data types for their respective applications.

Choose FEops HEARTguideTM if…

Choose FEops HEARTguideTM if you require advanced pre-procedural planning and predictive simulation for complex structural heart interventions like TAVI or LAAO. This platform is ideal for optimizing device sizing and positioning by leveraging AI-based anatomical measurements and interactive 2D/3D visualizations from CT scans.

View FEops HEARTguideTM →

Choose Zio ECG Utilization Software (ZEUS) System if…

Choose the Zio ECG Utilization Software (ZEUS) System if you need a comprehensive solution for long-term, continuous cardiac monitoring to diagnose and manage arrhythmias. This AI-powered platform excels at analyzing extended ECG data from wearable Zio monitors, providing detailed reports to aid in the detection and classification of cardiac rhythm disorders.

View Zio ECG Utilization Software (ZEUS) System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature FEops HEARTguideTM Zio ECG Utilization Software (ZEUS) System
Pricing Contact for pricing Unknown
Deployment Cloud-based Cloud-based.
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

FEops HEARTguideTM

Tool A emphasizes an interactive 2D and 3D viewer with semi-automatic and manual measurement options, providing clinicians with direct control and detailed interaction for complex procedure planning. This hands-on approach can enhance usability for its specific application in structural heart interventions. Tool B, while offering a web portal and mobile app, focuses more on streamlined reporting after automated analysis.

Clinical Value

FEops HEARTguideTM

While both tools offer significant clinical value in their respective domains, Tool A's predictive simulation technology directly impacts the efficiency and outcomes of complex structural heart interventions, such as TAVI and LAAO. Studies like PREDICT-LAA have shown it can significantly reduce device usage, repositioning, radiation, and procedural time, leading to improved patient safety and procedural success in high-stakes scenarios.

Pricing & Value

Tie

Neither FEops HEARTguideTM nor Zio ECG Utilization Software (ZEUS) System publicly discloses its pricing model. Both require direct contact for pricing information, making a direct comparison of their pricing and overall value proposition impossible based on available data.

Enterprise Readiness

Tie

Both tools demonstrate strong enterprise readiness, being cloud-based, FDA-cleared, HIPAA compliant, and BAA-ready. They also offer standard integration capabilities, with Tool A supporting DICOM and Tool B supporting HL7, ensuring seamless integration into existing clinical workflows.

Innovation

FEops HEARTguideTM

Tool A's utilization of 'digital twin' technology and predictive simulations for optimizing complex structural heart interventions represents a highly innovative approach to personalized procedural planning. This offers a groundbreaking method to anticipate device-anatomy interaction pre-operatively. While Tool B's deep-learned algorithms for ECG analysis are advanced, the core concept of AI-driven arrhythmia detection is a more established application of AI in healthcare.

Support & Docs

Zio ECG Utilization Software (ZEUS) System

Tool B provides more extensive and publicly accessible support documentation, including detailed Instructions for Use in multiple languages, a Clinical Reference Manual, and a dedicated Clinical Resource Center. It also explicitly lists customer care contact information, indicating a more structured and comprehensive support system. Tool A mentions email support and training slide decks but with less public detail.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature FEops HEARTguideTM Zio ECG Utilization Software (ZEUS) System
Name FEops HEARTguideTM Zio ECG Utilization Software (ZEUS) System
Company FEops nv iRhythm Technologies
Description FEops HEARTguideu2122 is a cloud-based AI and digital twin platform for structural heart procedure planning, providing predictive simulations and anatomical insights to optimize device sizing and positioning for interventions like TAVI and LAAO. The Zio ECG Utilization Software (ZEUS) System by iRhythm Technologies is an AI-powered, cloud-based platform that analyzes continuous ECG data from wearable Zio monitors to aid physicians in the diagnosis and management of cardiac arrhythmias.
Key Features Predictive simulation technology for device-anatomy interaction; AI-based anatomical measurements from CT scans; Cloud-based platform with access from anywhere at any time; DICOM interface for easy integration into clinical workflow; Semi-automatic and manual measurement options for anatomical landmarks; Interactive 2D and 3D viewer for detailed analysis; Segmentation of cardiovascular structures; Visualization and image reconstruction techniques (2D review, MPR) AI algorithm for arrhythmia detection and classification; Continuous ECG data analysis (up to 14 days); Cloud-based data analytics (AWS EC2 platform); Proprietary deep-learned algorithms for enhanced diagnostic accuracy; ZioSuite web portal and mobile application for healthcare professionals; Comprehensive end-of-wear reports for physician review; Integration with Zio wearable biosensors (Zio monitor, Zio Watch); HL7-based EHR integration
Specialties Cardiology, Cardiothoracic Surgery, Radiology Cardiology, Family Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring FEops HEARTguideTM and Zio ECG Utilization Software (ZEUS) System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

FEops HEARTguideTM is a cloud-based AI and digital twin platform for structural heart procedure planning, providing predictive simulations and anatomical insights to optimize device sizing and positioning for interventions like TAVI and LAAO. In contrast, the Zio ECG Utilization Software (ZEUS) System is an AI-powered, cloud-based platform that analyzes continuous ECG data from wearable Zio monitors to aid physicians in the diagnosis and management of cardiac arrhythmias.
FEops HEARTguideTM analyzes cardiac computed tomography (CT) scans to provide AI-based anatomical measurements and predictive simulations for structural heart interventions. The Zio ECG Utilization Software (ZEUS) System, however, processes continuous ECG data collected from Zio wearable biosensors for arrhythmia detection and classification.
FEops HEARTguideTM offers a DICOM interface for easy integration into clinical workflows, allowing for detailed analysis through its interactive 2D and 3D viewer. The Zio ECG Utilization Software (ZEUS) System provides HL7-based EHR integration and access for healthcare professionals via its ZioSuite web portal and mobile application.
FEops HEARTguideTM is primarily intended for specialists in Cardiology, Cardiothoracic Surgery, and Radiology, focusing on pre-procedural planning for structural heart interventions. The Zio ECG Utilization Software (ZEUS) System supports Cardiology, Family Medicine, and Internal Medicine, with its focus on cardiac arrhythmia diagnosis and management.
FEops HEARTguideTM delivers predictive simulations of device-anatomy interaction and AI-based anatomical measurements to optimize device sizing and positioning for structural heart procedures. The Zio ECG Utilization Software (ZEUS) System provides AI algorithms for arrhythmia detection and classification, generating comprehensive end-of-wear reports for physician review.

Backers

Who funded each tool's parent company.

Zio ECG Utilization Software (ZEUS) System

AI Tool Finder
AI-powered search. Results may not be comprehensive.